TUMOUR
COA 2020: No Improvement in Survival Trend for Surgically Treated Appendicular Bone Metastases
One hundred and three studies were included for analysis whereby all studies were non-randomized. The primary aim of the study was to evaluate the long-term trend in overall survival for patients with appendicular metastatic bone disease who underwent orthopaedic surgery for treatment within the last 50 years. No significant effect of mid-point study year on 1-year, 2-year, or 3-year survival were found (p=0.83; p=0.62; p=0.60, respectively). An association was not found between tumour severity score or 1-year survival. In general, no improvement was found in the overall survival of these patients over the past 50 years.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
